Single stage revision: Regaining momentum

Journal of Bone and Joint Surgery - Series B

Volumn 94 B, Issue 11 SUPPL.A, 2012, Pages 120-122

  Gulhane, S ^a   Vanhegan, I S ^a   Haddad, F S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; C REACTIVE PROTEIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BIOFILM; BONE DESTRUCTION; BONE INFECTION; CLINICAL FEATURE; COMORBIDITY; CONTRACTURE; DEBRIDEMENT; FOLLOW UP; GOLD STANDARD; HUMAN; INFECTION RATE; JOINT MOBILITY; KNEE ARTHROPLASTY; MIXED INFECTION; PRIORITY JOURNAL; REVIEW; TOTAL HIP PROSTHESIS; TREATMENT DURATION; TREATMENT RESPONSE;

ARTHROPLASTY, REPLACEMENT, KNEE; HUMANS; KNEE PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; REOPERATION; TREATMENT OUTCOME;

EID: 84870212681     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.94B11.30746     Document Type: Review

References (32)

1. Joulie D, Girard J, Mares O, et al. Factors governing the healing of Staphylococcus aureus infections following hip and knee prosthesis implantation: a retrospective study of 95 patients. Orthop Traumatol Surg Res 2011;97:685-692.
2. No authors listed. National Joint Registry for England and Wales: 8th Annual report, 2011. http://www.njrcentre.org.uk (date last accessed 23 August 2012).
3. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty: two-stage revision results. J Bone Joint Surg [Br] 2005;87-B:314-319. (Pubitemid 40424856)
4. Parvizi J, Zmistowski B, Adeli B. Periprosthetic joint infection: treatment options. Orthopedics 201;33:659.
5. Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res 2011;469:26-33.
6. Emerson RH Jr, Muncie M, Tarbox TR, Higgins LL. Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res 2002;404:132-138. (Pubitemid 35351062)
7. Van Thiel GS, Berend KR, Klein GR, et al. Intraoperative molds to create an articulating spacer for the infected knee arthroplasty. Clin Orthop Relat Res 2011;469:994-1001.
8. Garg P, Ranjan R, Bandyopadhyay U, et al. Antibiotic-impregnated articulating cement spacer for infected total knee arthroplasty. Indian J Orthop 2011;45:535-540.
9. Gooding CR, Masri BA, Duncan CP, Greidanus NV, Garbuz DS. Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty. Clin Orthop Relat Res 2011;469:985-993.
10. Calton TF, Fehring TK, Griffin WL. Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res 1997;345:148-154. (Pubitemid 28007497)
11. Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis: The Ranawat Award. Clin Orthop Relat Res 2000;380:9-16.
12. Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. Two stage revision knee arthroplasty for infection with massive bone loss: a technique to achieve spacer stability. Knee 2012;19:24-27.
13. Haddad FS, Masri BA, Campbell D, et al. The PROSTALAC functional spacer in two-stage revision for infected knee replacements: prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg [Br] 2000;82-B:807-812. (Pubitemid 30624038)
14. Meek RM, Masri BA, Dunlop D, et al. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg [Am] 2003;85-A:1888-1892. (Pubitemid 37259722)
15. Hofmann AA, Goldberg TD, Tanner AM, Cook TM. Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty 2005;20:874-879. (Pubitemid 41463687)
16. Hsieh PH, Shih CH, Chang YH, et al. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg [Am] 2004;86-A:1989-1997. (Pubitemid 39223467)
17. Younger AS, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 1997;12:615-623. (Pubitemid 27427939)
18. Vanhegan IS, Morgan-Jones R, Barrett DS, Haddad FS. Developing a strategy to treat established infection in total knee replacement: a review of the latest evidence and clinical practice. J Bone Joint Surg [Br] 2012;94-B:875-881.
19. Moyad TF, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics 2008;31:581-588. (Pubitemid 352007182)
20. Buechel FF. The infected total knee arthroplasty: just when you thought it was over. J Arthroplasty 2004;19(4 Suppl 1):51-55. (Pubitemid 38746717)
21. Brandt CM, Duffy MC, Berbari EF, et al. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999;74:553-558. (Pubitemid 29264772)
22. Vielpeau C, Lortat J. Les reprises de protheses totales de hanche infectees. Rev Chir Orthop. 2002;88(Suppl):S161-S208.
23. Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg [Br] 2008;90-B:1580-1584.
24. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection: long-term followup. Clin Orthop Relat Res 1995;321:202-207.
25. Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg [Br] 1994;76:721-724. (Pubitemid 24289557)
26. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement: an average ten-year follow-up. J Bone Joint Surg [Am] 1998;80:961-968. (Pubitemid 28355666)
27. Callaghan JJ, Katz RP, Johnston RC. One-stage revision surgery of the infected hip: a minimum 10-year followup study. Clin Orthop Relat Res 1999;369:139-143.
28. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg [Am] 2005;87-A:1746-1751. (Pubitemid 41061193)
29. Vanhegan IS, Malik AK, Jayakumar P, UL Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg [Br] 2012;94-B:619-623.
30. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001;32:419-430. (Pubitemid 32173628)
31. Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg [Br] 2010;92-B:1222-1226.
32. Haddad FS, Bridgens A. Infection following hip replacement: solution options. Orthopedics 2008;31:907-908.